1.Dimick, JB, Pelz, RK, Consunji, R, Swoboda, SM, Hendrix, CW, Lipsett, PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229–234.
2.Pittet, D. Nosocomial bloodstream infections in the critically ill. JAMA 1994;272:1819–1820.
3.Maki, DG, Anderson, RL, Shulman, JA. In-use contamination of intravenous fluid. Applied Microbiology 1974;28:778–784.
4.Maki, DG, Goldmann, DA, Rhame, FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867–887.
5.Centers for Disease Control and Prevention. Nosocomial bacteremia associated with intravenous fluid therapy. MMWR 1971;20:81–82.
6.Maki, DG, Rhame, FS, Mackel, DC, Bennett, JV. Nationwide epidemic of septicemia caused by contaminated intravenous products: I. Epidemiologic and clinical features. Am J Med 1976;60:471–485.
7.Band, JD, Maki, DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979;91:173–178.
8.Buxton, AE, Highsmith, AK, Garner, JS, et al.Contamination of intravascular infusion fluid: effects of changing administration sets. Ann Intern Med 1979;90:764–768.
9.Gorbea, HF, Snydman, DR, Delaney, A, Stockman, J, Martin, WJ. Intravenous tubing with burettes can be safely changed at 48-hour intervals. JAMA 1984;251:2112–2115.
10.deMoissac, D, Jensen, L. Changing i.v. administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer? Oncol Nurs Forum 1998;25:907–913.
11.Maki, DG, Botticelli, JT, LeRoy, ML, Thielke, TS. Prospective study of replacing administration sets for intravascular therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA 1987;258:1777–1781.
12.Snydman, DR, Donnelly-Reidy, M, Perry, LK, Martin, WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987;8:113–116.
13.Robathan, G, Woodger, S, Merante, D. A prospective study evaluating the effects of extending total parenteral nutrition line changes to 72 hours. Journal of Intravenous Nursing 1995;18:84–87.
14.Matlow, AG, Kitai, I, Kirpalani, H, et al.A randomized controlled trial of 72- versus 24-hour intravenous tubing administration set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol 1999;20:487–493.
15.Cohen, DM. A replication study: analysis of bacterial contamination of intravenous administration sets in use for 72 hours. Journal of the New York State Nurses Association 1989;20:12.
16.Fox, M, Molesky, M, Van Aerde, JE, Muttitt, S. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants. Can J Gastroenterol 1999;13:147–151.
17.Sitges-Serra, A, Linares, J, Perez, JL, Jaurrieta, E, Lorente, L, A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985;9:322–325.
18.Josephson, A, Gombert, ME, Sierra, MF, Karanfil, LV, Tansino, GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367–370.
19.Raad, I, Hanna, HA, Awad, A, et al.Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001;22:136–139.
20.Jakobsen, CJ, Grabe, N, Nielsen, E, et al.Contamination of intravascular infusion systems: the effect of changing administration sets. J Hosp Infect 1986;8:217–223.
21.O'Grady, NP, Alexander, M, Dellinger, EP, et al.Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51:1–29.
22.Maki, DG, Weise, CE, Sarafin, HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305–1309.
23.Bone, RC, Balk, RA, Cerra, FB, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644–1655.
24.Fraenkel, DJ, Rickard, C, Lipman, J. Can we achieve consensus on central venous catheter-related infections? Anaesth Intensive Care 2000;28:475–490.
25.Elliott, TSJ, Moss, HA, Tebbs, SE, et al.Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997;16:210–213.
26.Ducharme, FM, Gauthier, M, Lacroix, J, Lafleur, L. Incidence of infection related to arterial catheterization in children: a prospective study. Crit Care Med 1988;16:272–276.
27.Polderman, KH, Girbes, ARJ. Central venous catheter use: Part 2. infectious complications. Intensive Care Med 2002;28:18–28.
28.Veenstra, DL, Saint, S, Saha, S, Lumley, T, Sullivan, SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261–267.
29.Cohen, J. Statistical Power Analysis for the Behavioural Sciences. Mahwah, NJ: Lawrence Erlbaum Associates; 1988.
30.Eggimann, P, Pittett, D. Catheter-related infections in the ICU. In: Vincent, JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer Verlag; 2000:95–110.
31.O'Malley, MK, Rhame, FS, Cerra, FB, McComb, RC. Value of routine pressure monitoring system changes after 72 hours of continuous use. Crit Care Med 1994;22:1424–1430.
32.Chen, YY, Lin, M, Lin, MY, Wang, FD, Liu, JH, Chang, MS. The central venous tubing change associated with catheter-related infection. Infect Control Hosp Epidemiol 2000;21:94.
33.Rickard, C, Wallis, SC, Courtney, M, Lipman, J, Daley, PJP. Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use: an in vitro study. J Adv Nurs 2002;37:330–337.
34.Walters, AJ. A Heideggerian hermeneutic study of the practice of critical care nurses. J Adv Nurs 1995;21:492–497.